Antagoniste de la vitamine K (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antagoniste de la vitamine K" in French language version.

refsWebsite

Global rank French rank

5nih.gov

4^th place

12^th place

3doi.org

2^nd place

3^rd place

2ahajournals.org

3,608^th place

659^th place

1chestjournal.org

low place

1oxfordjournals.org

1,389^th place

508^th place

1pharmacorama.com

low place

5,927^th place

1wiley.com

222^nd place

129^th place

1acs.org

1,248^th place

778^th place

1schattauer.de

low place

1springer.com

274^th place

223^rd place

1jamanetwork.com

2,650^th place

689^th place

1afssaps.fr

low place

3,181^st place

1nutrition.org

7,878^th place

3,663^rd place

acs.org

pubs.acs.org

Rettie AE, Korzekwa KR, Kunze KL et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-450 2C9 in the etiology of (S)-warfarin-drug interactions, Chem Res Toxicol, 1992;5:54–59

afssaps.fr

Dossier AFSSAPS, consulté 2010/12/13

ahajournals.org

circ.ahajournals.org

Mueller RL, Scheidt S, History of drugs for thrombotic disease: discovery, development, and directions for the future, Circulation, 1994;89:432–449

circoutcomes.ahajournals.org

Singer DE, Chang Y, Fang MC et al. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?, Circ Cardiovasc Qual Outcomes, 2009;2:297-304

chestjournal.org

(en) Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, « Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) », Chest, vol. 133, n^o 6 Suppl,‎ juin 2008, p. 160S–198S (PMID 18574265, DOI 10.1378/chest.08-0670, lire en ligne)

doi.org

dx.doi.org

(en) Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, « Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) », Chest, vol. 133, n^o 6 Suppl,‎ juin 2008, p. 160S–198S (PMID 18574265, DOI 10.1378/chest.08-0670, lire en ligne)
(en) Mentré F, Pousset F, Comets E, et al., « Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients », Clin. Pharmacol. Ther., vol. 63, n^o 1,‎ janvier 1998, p. 64–78 (PMID 9465843, DOI 10.1016/S0009-9236(98)90122-9)
(en) Schaefer C, Hannemann D, Meister R, et al., « Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study », Thromb. Haemost., vol. 95, n^o 6,‎ juin 2006, p. 949–57 (PMID 16732373, DOI 10.1160/TH06-02-0108, lire en ligne)

jamanetwork.com

Caraballo PJ, Heit JA, Atkinson EJ et al. Long-term use of oral anticoagulants and the risk of fracture, Arch Intern Med, 1999;159:1750-1756

nih.gov

ncbi.nlm.nih.gov

(en) Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, « Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) », Chest, vol. 133, n^o 6 Suppl,‎ juin 2008, p. 160S–198S (PMID 18574265, DOI 10.1378/chest.08-0670, lire en ligne)
(en) Mentré F, Pousset F, Comets E, et al., « Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients », Clin. Pharmacol. Ther., vol. 63, n^o 1,‎ janvier 1998, p. 64–78 (PMID 9465843, DOI 10.1016/S0009-9236(98)90122-9)
Schurgers LJ et al., Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype, Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 2012
(en) Schaefer C, Hannemann D, Meister R, et al., « Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study », Thromb. Haemost., vol. 95, n^o 6,‎ juin 2006, p. 949–57 (PMID 16732373, DOI 10.1160/TH06-02-0108, lire en ligne)
(en) Griminger P, « Vitamin K antagonists: the first 50 years », J. Nutr., vol. 117, n^o 7,‎ juillet 1987, p. 1325–9 (PMID 3302140, lire en ligne)

nutrition.org

jn.nutrition.org

(en) Griminger P, « Vitamin K antagonists: the first 50 years », J. Nutr., vol. 117, n^o 7,‎ juillet 1987, p. 1325–9 (PMID 3302140, lire en ligne)

oxfordjournals.org

eurheartjsupp.oxfordjournals.org

(en) « Foreword: contemporary issues in the management and treatment of atrial fibrillation -- Agnelli 7 (2005): C3 -- European Heart Journal Supplements » (consulté le 22 décembre 2008)

pharmacorama.com

Pharmacorama, Médicaments modifiant la synthèse de facteurs de la coagulation, sur pharmacorama.com (consulté le 21 novembre 2012)

schattauer.de

(en) Schaefer C, Hannemann D, Meister R, et al., « Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study », Thromb. Haemost., vol. 95, n^o 6,‎ juin 2006, p. 949–57 (PMID 16732373, DOI 10.1160/TH06-02-0108, lire en ligne)

springer.com

link.springer.com

Sugiyama T, Kugimiya F, Kono S, Kim YT, Oda H, Warfarin use and fracture risk: an evidence-based mechanistic insight, Osteoporos Int, 2015;26:1231-1232

wiley.com

mrw.interscience.wiley.com

Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ, Self-monitoring and self-management of oral anticoagulation, Cochrane Database of Systematic Reviews, 2010, Issue 4. Art. No.: CD003839